Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 5
2017 4
2018 7
2019 7
2020 2
2021 4
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study.
Nabergoj Makovec U, Goetzinger C, Ribaut J, Barnestein-Fonseca P, Haupenthal F, Herdeiro MT, Grant SP, Jácome C, Roque F, Smits D, Tadic I, Dima AL; European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE); European Network to Advance Best Practices and TechnoLogy on Medication AdherencE (ENABLE). Nabergoj Makovec U, et al. BMJ Open. 2022 Apr 22;12(4):e059674. doi: 10.1136/bmjopen-2021-059674. BMJ Open. 2022. PMID: 35459677 Free PMC article.
European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement.
van Boven JF, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, Ágh T, Kardas P, Ghiciuc CM, Petrova G, Bitterman N, Kamberi F, Culig J, Wettermark B. van Boven JF, et al. Among authors: potocnjak i. Front Pharmacol. 2021 Oct 11;12:748702. doi: 10.3389/fphar.2021.748702. eCollection 2021. Front Pharmacol. 2021. PMID: 34707502 Free PMC article.
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action.
Lecour S, Andreadou I, Bøtker HE, Davidson SM, Heusch G, Ruiz-Meana M, Schulz R, Zuurbier CJ, Ferdinandy P, Hausenloy DJ; on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225. Lecour S, et al. Basic Res Cardiol. 2021 Sep 13;116(1):52. doi: 10.1007/s00395-021-00893-5. Basic Res Cardiol. 2021. PMID: 34515837 Free PMC article. Review.
Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129.
Badimon L, Robinson EL, Jusic A, Carpusca I, deWindt LJ, Emanueli C, Ferdinandy P, Gu W, Gyöngyösi M, Hackl M, Karaduzovic-Hadziabdic K, Lustrek M, Martelli F, Nham E, Potočnjak I, Satagopam V, Schneider R, Thum T, Devaux Y. Badimon L, et al. Among authors: potocnjak i. Cardiovasc Res. 2021 Jul 7;117(8):1823-1840. doi: 10.1093/cvr/cvab094. Cardiovasc Res. 2021. PMID: 33839767 Free PMC article.
35 results